HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy.

AuthorsPasquale Niscola, Andrea Tendas, Laura Scaramucci, Roberta Merola, Gianfranco Catalano, Paolo de Fabritiis
JournalBlood research (Blood Res) Vol. 49 Issue 2 Pg. 130-7 (Jun 2014) ISSN: 2287-979X [Print] Korea (South)
PMID25025016 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: